Table 3.

Association between baseline myelomalacia and clinical, imaging and histopathological features [Fisher's exact test (two-sided)].

Variable	Baseline myelomalacia	No baseline myelomalacia	p-value
Age
≥66 years	44 (57.3%)	32 (42.7%)	0.27
<66 years	22 (45.8%)	26 (54.2%)
Baseline symptom duration
<4 weeks	11 (34.4%)	21 (65.6%)	0.02
≥4 weeks	54 (59.3%)	37 (40.7%)
Location
Cervical	1 (50.0%)	1 (50.0%)	0.99
Thoracic	48 (53.3%)	42 (46.7%)
Lumbar	16 (51.6%)	15 (48.4%)
WHO grade
I	61 (53.5%)	53 (46.5%)	0.73
II	4 (44.4%)	5 (55.6%)
Dural attachment site
Ventral	22 (59.5%)	15 (40.5%)	0.37
Lateral	22 (44.9%)	27 (55.1%)
Dorsal	20 (55.6%)	16 (44.4%)
Involved spinal segments
≤ 2 segments	57 (51.8%)	53 (48.2%)	0.11
>2 segments	8 (80.0%)	2 (20.0%)